Beta disubstituted metalloprotease inhibitors
CA 2386485 A1 · Owner: Solinsky, Kelly Michelle · Inventors: De, Biswanath; Solinsky, Kelly Michelle; Ohler, Norman Eugene
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have a structure according to Formula (I), wherein R1, R2, R3, R4, R5, R6, G and Z have the meanings described in the specification. This invention also includes optical isomers diastereomers , and enantiomers of Formula (I) and pharmaceutically-acceptable salts, biohydrolyzable amides esters, and imides thereof. Also described are pharmaceutical compositions comprising these compounds and methods of , treating metalloprotease-related maladies using the compounds or the pharmaceutical …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 12, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 12, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 12, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.